Found 8 matching trials
A Study Assessing GW870086's Potential to Cause Skin Thinning PHASE1 This study is a randomised, double-blind, placebo-controlled study of topic...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers. PHASE1 This study is a randomised, double-blind, placebo-controlled, dose ascendin...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo PHASE2 This study is a randomised, double-blind, placebo-controlled study to asses...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers PHASE1 GW870086X is a novel inhaled steroid that has an improved safety profile ov...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics PHASE2 The study will measure the early and late asthamtic response using an aller...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male Subjects PHASE1 This study was designed to look at safety aspects and effects of repeat inh...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1) PHASE2 This is a randomised, double-blind, placebo-controlled, parallel group stud...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics PHASE2 This study will measure the effect of repeat inhaled doses of GW870086X on ...
Show More Location
GSK Investigational Site
Learn More & Join Trial